HF
CYT

HRT Financial’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

HRT Financial’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,015
Closed -$48K – 3338
2023
Q4 		$48K Buy
+16,015
New +$48.6K ﹤0.01% 1961

Other funds holding CYT

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

HRT Financial's CYT Position: Q1 2024 in Review

HRT Financial sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q1 2024, closing a stake of 16,015 shares — an estimated $48K sold.

HRT Financial first reported a position in CYT in Q4 2023 and held it in 1 quarter. The position peaked at $48K in Q4 2023. 4 funds tracked by Wall St. Rank hold CYT as of Q1 2024.

  • HRT Financial reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • HRT Financial sold 16,015 Cyteir Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $48K.
  • HRT Financial first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • HRT Financial's Cyteir Therapeutics, Inc. Common Stock position peaked at $48K in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.